Publications

5891 Results

Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup protocol INT-0102

Authors
LF Hutchins;SJ Green;PM Ravdin;D Lew;S Martino;M Abeloff;AP Lyss;C Allred;SE Rivkin;CK Osborne
Journal / Conference
Journal of Clinical Oncology 23(33):8313-8321
Year
2005
Research Committee(s)
Breast
Study Number(s)
SWOG-8897

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group

Authors
SA Scudder;PY Liu;SP Wilczynski;HO Smith;C Jiang;AV Hallum III;GB Smith;EV Hannigan;M Markman;DS Alberts
Journal / Conference
Gynecologic Oncology 96:610-615
Year
2005
Research Committee(s)
Gynecologic
Study Number(s)
S9720

Estimated impact of the prostate cancer prevention trial on population mortality

Authors
JM Unger;IM Thompson;M LeBlanc;JJ Crowley;PJ Goodman;LG Ford;CA Coltman Jr
Journal / Conference
Cancer 103(7):1375-1380
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

A phase II study of flavopirodol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109

Authors
PJ Van Veldhuizen;JR Faulkner;PN Lara Jr;PH Gumerlock;J Wendall Goodwin;SR Dakhil;HM Gross;RC Flanigan;ED Crawford
Journal / Conference
Cancer Chemotherapy and Pharmacology 56:39-45
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
S0109

Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.

Authors
HL West;JJ Crowley;RB Vance;WA Franklin;RB Livingston;SR Dakhil;JK Giguere;SE Rivkin;MJ Kraut;K Chansky;DR Gandara
Journal / Conference
Annals of Oncology 16:1076-1080
Year
2005
Research Committee(s)
Lung
Study Number(s)
S9714

Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group trial

Authors
SG Urba;J Moon;PGS Giri;DJ Adelstein;E Hanna;GH Yoo;M LeBlanc;JF Ensley;DE Schuller
Journal / Conference
Journal of Clinical Oncology 23(1):88-95
Year
2005
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9451

Designing the selenium and vitamin E cancer prevention trial (SELECT)

Authors
SM Lippman;PJ Goodman;EA Klein;HL Parnes;IM Thompson, Jr;AR Kristal;RM Santella;JL Probstfield;CM Moinpour;D Albanes;PR Taylor;LM Minasian;A Hoque;SM Thomas;JJ Crowley;JM Gaziano;JL Stanford;ED Cook;NE Fleshner;MM Lieber;PJ Walther;FR Khuri;DD Karp;GG Schwartz;LG Ford;CA Coltman, Jr
Journal / Conference
Journal of the National Cancer Intitute 97(2):94-102
Year
2005
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer. A Southwest Oncology Group (SWOG 9924) study.

Authors
JS Macdonald;S McCoy;RP Whitehead;S Iqbal;JL Wade;JK Giguere;Jl Abbruzzese
Journal / Conference
Investigational New Drugs 23:485-487
Year
2005
Research Committee(s)
Gastrointestinal
Study Number(s)
S9924

Centralized blood processing for the Selenium and Vitamin E Cancer Prevention Trial: Effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones and lymphocyte viability

Authors
AR Kristal;IB King;D Albanes;MN Pollak;FZ Stanzyk;RM Santella;A Hoque
Journal / Conference
Cancer Biomarkers & Prevention 14(3):727-730
Year
2005
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

SWOG 0127: phase II trial of erlotinib in GEJ and gastric adenocarcinomas

Authors
T Dragovich;S McCoy;SG Urba;KS Zaner;CM Fenoglio-Preiser;CD Blanke;JL Abbruzzese
Journal / Conference
ASCO 2005 Gastrointestinal Cancers Symposium #49
Year
2005
Research Committee(s)
Gastrointestinal
Study Number(s)
S0127